Risk of second primary malignancies after adjuvant chemotherapy for colon cancer
Oxaliplatin-based adjuvant chemotherapy was associated with a heightened long-term risk of SPMs, particularly second colorectal cancers. These findings highlight the need for risk-adapted survivorship care strategies.
Authors
- Ladislav Dušek (ORCID: https://orcid.org/0000-0002-8589-4378)
- Petr Klika
- Monika Ambrozova
- Ondřej Májek (ORCID: https://orcid.org/0000-0002-0034-3084)
- Tomáš Büchler (ORCID: https://orcid.org/0000-0001-6667-994X)
- Tereza Dianova
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital in Motol (CZ)
- Institute of Health Information and Statistics (CZ)
Publication Details
- Journal
- Cancer
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1002/cncr.70116
- Primary Topic
- Multiple and Secondary Primary Cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.00